China Nuokang Bio-Pharmaceutical Inc. is a leading, fully integrated, profitable biopharmaceutical company focused on researching,
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Shenyang
State: Liaoning
Zip:
Country: China
China Nuokang Bio-Pharmaceutical Inc. is a fully integrated, profitable bio-pharmaceutical company focused on researching, developing, manufacturing and marketing hematological and cardiovascular products. They sell a portfolio of fourteen products, which includes principal products Baquting®, a flagship hemocoagulase, and Aiduo®, a cardiovascular stress imaging agent. There product pipeline includes product candidates under development in hematological, cardiovascular and cerebrovascular disease diagnosis, treatment and prevention.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
12/10/2009
Ticker Symbol:
NKBP
IPO Price:
$9/share
Amount Raised:
$45M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2008 | Venture Round | 1 | $17M |
Sequoia Capital China Sequoia Capital China |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|